Skip to main content
All lobbying clients

AMERICAN SOCIETY OF ADDICTION MEDICINE

Lobbying client · Maryland · filed 2025 to 2026

Medical Professional Society

$300,000 Reported spend
6 Filings counted
1 Firms hired
17 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (202836), not by name.

 Firms hired 1
 Bills named in these filings 17
  • S 644
    Modernizing Opioid Treatment Access Act
    3 filings
  • S 1941
    Cure Hepatitis C Act of 2025
    2 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    1 filing
  • HR 1510
    Due Process Continuity of Care Act
    1 filing
  • HR 1627
    TREATS Act
    1 filing
  • HR 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
    1 filing
  • HR 2509
    COMPLETE Care Act
    1 filing
  • HR 2586
    Reentry Act of 2025
    1 filing
  • HR 27
    HALT Fentanyl Act
    1 filing
  • HR 4731
    Resident Physician Shortage Reduction Act of 2025
    1 filing
  • HR 5629
    To provide that the final rule of the Department of Health and Human Services titled "Medications for the Tre…
    1 filing
  • HR 879
    Medicare Patient Access and Practice Stabilization Act of 2025
    1 filing
  • HR 9538
    Residential Recovery for Seniors Act
    1 filing
  • S 1036
    Improving Access to Addiction Medicine Providers Act
    1 filing
  • S 2493
    Medical Disability Examination Improvement Act of 2025
    1 filing
  • S 331
    HALT Fentanyl Act
    1 filing
  • S 4941
    Modernizing Opioid Treatment Access Act 2.0 of 2026
    1 filing
 Reported by year 2 years
  • 2026 $80,000 2 filings
  • 2025 $220,000 4 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 10
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Congressional Budget Office (CBO) 6
  • Drug Enforcement Administration (DEA) 6
  • Food & Drug Administration (FDA) 6
  • Health & Human Services, Dept of (HHS) 6
  • Health Resources & Services Administration (HRSA) 6
  • HOUSE OF REPRESENTATIVES 6
  • Office of Natl Drug Control Policy (NDCP) 6
  • SENATE 6
  • Substance Abuse & Mental Health Services Administration (SAMHSA) 6
 Recent filings 6 total
Q2
AMERICAN SOCIETY OF ADDICTION MEDICINE
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 expenses · posted Jul 17, 2026
View → Q1
AMERICAN SOCIETY OF ADDICTION MEDICINE
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 expenses · posted Apr 15, 2026
View → Q4
AMERICAN SOCIETY OF ADDICTION MEDICINE
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $70,000 expenses · posted Jan 17, 2026
View → Q3
AMERICAN SOCIETY OF ADDICTION MEDICINE
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $70,000 expenses · posted Oct 17, 2025
View → Q2
AMERICAN SOCIETY OF ADDICTION MEDICINE
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $30,000 expenses · posted Jul 15, 2025
View → Q1
AMERICAN SOCIETY OF ADDICTION MEDICINE
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 expenses · posted Apr 18, 2025
View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem